PL308551A1 - Application of bhpa compounds in combination with other nucleosidal inhibitors of reverse transcriptase in treating hiv infections - Google Patents

Application of bhpa compounds in combination with other nucleosidal inhibitors of reverse transcriptase in treating hiv infections

Info

Publication number
PL308551A1
PL308551A1 PL93308551A PL30855193A PL308551A1 PL 308551 A1 PL308551 A1 PL 308551A1 PL 93308551 A PL93308551 A PL 93308551A PL 30855193 A PL30855193 A PL 30855193A PL 308551 A1 PL308551 A1 PL 308551A1
Authority
PL
Poland
Prior art keywords
nucleosidal
bhpa
inhibitors
compounds
combination
Prior art date
Application number
PL93308551A
Inventor
William Gary Tarpley
Thomas Jerome Dueweke
Donald Herman M D Batts
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of PL308551A1 publication Critical patent/PL308551A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL93308551A 1992-10-28 1993-09-10 Application of bhpa compounds in combination with other nucleosidal inhibitors of reverse transcriptase in treating hiv infections PL308551A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96763992A 1992-10-28 1992-10-28
US1711993A 1993-02-12 1993-02-12

Publications (1)

Publication Number Publication Date
PL308551A1 true PL308551A1 (en) 1995-08-21

Family

ID=26689480

Family Applications (1)

Application Number Title Priority Date Filing Date
PL93308551A PL308551A1 (en) 1992-10-28 1993-09-10 Application of bhpa compounds in combination with other nucleosidal inhibitors of reverse transcriptase in treating hiv infections

Country Status (12)

Country Link
EP (1) EP0666744A1 (en)
JP (1) JPH08502745A (en)
KR (1) KR950703958A (en)
AU (1) AU4848293A (en)
CA (1) CA2145545A1 (en)
CZ (1) CZ69695A3 (en)
FI (1) FI952018A0 (en)
HU (1) HUT72050A (en)
MX (1) MX9306031A (en)
NO (1) NO951608L (en)
PL (1) PL308551A1 (en)
WO (1) WO1994009781A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
WO2002072548A2 (en) 2001-03-09 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Heterocyclic compounds and their use as histamine h4 ligands.
UA79309C2 (en) 2002-09-06 2007-06-11 Janssen Pharmaceutica Nv Heterocyclic compounds
US8541407B2 (en) 2010-03-31 2013-09-24 Arqule, Inc. Substituted benzo-pyrido-triazolo-diazepine compounds
TW201307347A (en) 2010-11-01 2013-02-16 Arqule Inc Substituted benzo-imidazo-pyrido-diazepine compounds

Also Published As

Publication number Publication date
FI952018A (en) 1995-04-27
EP0666744A1 (en) 1995-08-16
AU4848293A (en) 1994-05-24
HU9501218D0 (en) 1995-06-28
CA2145545A1 (en) 1994-05-11
MX9306031A (en) 1994-04-29
HUT72050A (en) 1996-03-28
NO951608L (en) 1995-06-28
WO1994009781A1 (en) 1994-05-11
FI952018A0 (en) 1995-04-27
NO951608D0 (en) 1995-04-27
KR950703958A (en) 1995-11-17
JPH08502745A (en) 1996-03-26
CZ69695A3 (en) 1995-12-13

Similar Documents

Publication Publication Date Title
EP0462800A3 (en) Inhibitors of hiv reverse transcriptase
AU2216292A (en) Inhibitors of hiv reverse transcriptase
IL99843A0 (en) Synergistic combination of hiv reverse transcriptase inhibitors
FI953954A (en) Inhibitors of HIV reverse transcriptase
ZA896864B (en) Method and composition for the treatment and prevention of viral infections
AU2436792A (en) Quinazoline derivatives as inhibitors of hiv reverse transcriptase
AU1046895A (en) New quinazolines as inhibitors of hiv reverse transcriptase
AU5590596A (en) Use of calpain inhibitors in the inhibition and treatment of neurodegeneration
EP0643580A4 (en) Combinations of ace inhibitors and diuretics.
AU3959193A (en) Heterocyclic compounds and their use in the treatment of type II-diabetes
GB9323044D0 (en) In or relating to the treatment of effluents
EE03150B1 (en) Use of quinoline-3-carbosamide compounds in the preparation of a composition for antitumor and septic shock
EP0559791A4 (en) Treatment of topical infections
GB9320785D0 (en) Dibenzylheterocyclic or dibenzylcycloalkyl derivatives as inhibitors of hiv intergrase
AU5871694A (en) Combination for treating hiv infections containing thymosine, interleukin and hiv replication or reverse transcriptase inhibitors
HUT71401A (en) New quinazolines as inhibitors of hiv reverse transcriptase
PL308551A1 (en) Application of bhpa compounds in combination with other nucleosidal inhibitors of reverse transcriptase in treating hiv infections
HUT77573A (en) Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors
AU1870292A (en) Use of neutral endopeptidase inhibitors in the treatment of nephrotoxicity
EP0462808A3 (en) Inhibitors of hiv reverse transcriptase
PL317876A1 (en) Combined treatment of hiv infections
GB9308781D0 (en) Inhibitors of hiv reverse transcriptase
EP0717622A4 (en) Methods of treating hiv with azaspiranes
ZA914653B (en) Inhibitors of hiv reverse transcriptase
ZA935724B (en) Benzoxazinones as inhibitors of HIV reverse transcriptase